225 related articles for article (PubMed ID: 37239833)
1. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase.
He XY; Dobkin C; Brown WT; Yang SY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833
[TBL] [Abstract][Full Text] [Related]
2. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
He XY; Dobkin C; Brown WT; Yang SY
J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658
[TBL] [Abstract][Full Text] [Related]
3. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
He XY; Isaacs C; Yang SY
J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer's Disease.
He XY; Frackowiak J; Dobkin C; Brown WT; Yang SY
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139430
[TBL] [Abstract][Full Text] [Related]
5. Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders.
Yang SY; He XY; Isaacs C; Dobkin C; Miller D; Philipp M
J Steroid Biochem Mol Biol; 2014 Sep; 143():460-72. PubMed ID: 25007702
[TBL] [Abstract][Full Text] [Related]
6. Comparative evolutionary genomics of the HADH2 gene encoding Abeta-binding alcohol dehydrogenase/17beta-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10).
Marques AT; Antunes A; Fernandes PA; Ramos MJ
BMC Genomics; 2006 Aug; 7():202. PubMed ID: 16899120
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
[TBL] [Abstract][Full Text] [Related]
8. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
Yang SY; He XY; Schulz H
Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
Yang SY; He XY; Miller D
Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
[TBL] [Abstract][Full Text] [Related]
10. 6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation.
Benek O; Hroch L; Aitken L; Dolezal R; Guest P; Benkova M; Soukup O; Musil K; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Med Chem; 2017 Jan; ():. PubMed ID: 28067167
[TBL] [Abstract][Full Text] [Related]
11. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457
[No Abstract] [Full Text] [Related]
12. A 5-methylcytosine hotspot responsible for the prevalent HSD17B10 mutation.
Yang SY; Dobkin C; He XY; Philipp M; Brown WT
Gene; 2013 Feb; 515(2):380-4. PubMed ID: 23266819
[TBL] [Abstract][Full Text] [Related]
13. HSD10 disease: clinical consequences of mutations in the HSD17B10 gene.
Zschocke J
J Inherit Metab Dis; 2012 Jan; 35(1):81-9. PubMed ID: 22127393
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase.
He XY; Yang YZ; Schulz H; Yang SY
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):139-43. PubMed ID: 10600649
[TBL] [Abstract][Full Text] [Related]
15. Friend or enemy? Review of 17β-HSD10 and its role in human health or disease.
Vinklarova L; Schmidt M; Benek O; Kuca K; Gunn-Moore F; Musilek K
J Neurochem; 2020 Nov; 155(3):231-249. PubMed ID: 32306391
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
[TBL] [Abstract][Full Text] [Related]
17. Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.
Deutschmann AJ; Amberger A; Zavadil C; Steinbeisser H; Mayr JA; Feichtinger RG; Oerum S; Yue WW; Zschocke J
Hum Mol Genet; 2014 Jul; 23(13):3618-28. PubMed ID: 24549042
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular analysis of 6 Chinese patients with isoleucine metabolism defects: identification of 3 novel mutations in the HSD17B10 and ACAT1 gene.
Su L; Li X; Lin R; Sheng H; Feng Z; Liu L
Metab Brain Dis; 2017 Dec; 32(6):2063-2071. PubMed ID: 28875337
[TBL] [Abstract][Full Text] [Related]
19. Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias.
Kristofikova Z; Ricny J; Vyhnalek M; Hort J; Laczo J; Sirova J; Klaschka J; Ripova D
J Alzheimers Dis; 2015; 48(1):105-14. PubMed ID: 26401932
[TBL] [Abstract][Full Text] [Related]
20. Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism.
Yang SY; He XY; Olpin SE; Sutton VR; McMenamin J; Philipp M; Denman RB; Malik M
Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14820-4. PubMed ID: 19706438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
